| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/24/2002 | WO2002006524A2 A method for direct genetic analysis of target cells by using flourescence probes |
| 01/24/2002 | WO2002006523A2 Method for detecting pre-disposition to hepatotoxicity |
| 01/24/2002 | WO2002006521A1 Identification of two principal mutations in ion channels associated with idiopathic generalised epilepsies |
| 01/24/2002 | WO2002006511A2 Methods for detecting and assaying nucleic acid sequences |
| 01/24/2002 | WO2002006510A2 Photoselection of nucleic acid ligands |
| 01/24/2002 | WO2002006502A2 Adenovirus vectors comprising introns |
| 01/24/2002 | WO2002006501A2 Method for altering degradation of engineered protein in plant cells |
| 01/24/2002 | WO2002006500A2 Methods of transforming plants and identifying parental origin of a chromosome in those plants |
| 01/24/2002 | WO2002006499A2 Zmaxig1-specific polynucleotides and methods of use |
| 01/24/2002 | WO2002006498A1 Molecular control of transgene segregation and its escape by a recoverable block of function (rbf) system |
| 01/24/2002 | WO2002006497A2 Transplastomic plants |
| 01/24/2002 | WO2002006496A1 Seed composition and method for reducing and preventing the release of genetically manipulated pollen |
| 01/24/2002 | WO2002006495A2 Mutant muscle-specific enhancers |
| 01/24/2002 | WO2002006494A1 Recombinant plasmid pdsbcm, microorganisms transformed therewith, and method for producing an alkaline protease vapk |
| 01/24/2002 | WO2002006493A1 Recombinant plasmid psp1, microorganisms transformed therewith, and method for producing an alkaline protease vapk |
| 01/24/2002 | WO2002006492A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 01/24/2002 | WO2002006491A1 Isopentenyl pyrophosphate isomerase |
| 01/24/2002 | WO2002006490A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 01/24/2002 | WO2002006489A1 A novel polypeptide, a human cytochrome c oxidase subunit 8.91 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006487A2 Regulatory sequences from meristematic cells |
| 01/24/2002 | WO2002006486A1 Fused protein with antitumor effect |
| 01/24/2002 | WO2002006485A2 47885, a novel human ubiquitin-activating enzyme and uses therefor |
| 01/24/2002 | WO2002006484A1 Method of detecting cancer |
| 01/24/2002 | WO2002006483A1 Novel physiologically active peptide and use thereof |
| 01/24/2002 | WO2002006482A1 Receptor protein specifically recognizing bacterial dna |
| 01/24/2002 | WO2002006481A1 Target of anticancer agent |
| 01/24/2002 | WO2002006480A2 Tissue inhibitors of matrix metalloproteinases |
| 01/24/2002 | WO2002006479A2 Apoptosis-inducing dna sequences |
| 01/24/2002 | WO2002006478A2 Extracellular matrix protein |
| 01/24/2002 | WO2002006477A1 A novel polypeptide-homo topoisomerase 12.1 and polynucleotide encoding said polypeptide |
| 01/24/2002 | WO2002006476A1 A novel polypeptide, a human cytokine receptor 10.67 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006475A1 A NOVEL POLYPEPTIDE, A PREGNANCY SPECIFIC β 1-GLUCOPROTEIN 9.02 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 01/24/2002 | WO2002006474A1 A novel polypeptide, a human ehd protein 12.1 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006473A1 A novel polypeptide, a human estrogen receptor relative protein 10.01 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006472A1 A novel polypeptide, a human nucleoprotein 10.45 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006471A1 A novel polypeptide, a nucleophosmin9.68 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006470A1 A novel polypeptide, a human myoglobulin ixa11.88 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006469A2 Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids |
| 01/24/2002 | WO2002006468A2 METHYL CpG BINDING DOMAIN NUCLEIC ACIDS FROM MAIZE |
| 01/24/2002 | WO2002006466A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/24/2002 | WO2002006465A2 7677, a novel human atpase family member and uses therefor |
| 01/24/2002 | WO2002006463A2 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 01/24/2002 | WO2002006462A2 Methylated nucleotide regulation of upa gene expression |
| 01/24/2002 | WO2002006461A2 Inhibitors of plant peptide deformylase for use as broad-spectrum herbicides and methods for identifying the same |
| 01/24/2002 | WO2002006460A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | WO2002006459A1 Process for the fermentative preparation of l-threonine |
| 01/24/2002 | WO2002006458A2 Protease specific cleavable luciferases and methods of use thereof |
| 01/24/2002 | WO2002006457A2 Novel lipase genes |
| 01/24/2002 | WO2002006453A2 Regulation of human desc1-like serine protease |
| 01/24/2002 | WO2002006452A2 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 01/24/2002 | WO2002006451A1 Tissue-specific self-inactivating gene therapy vector |
| 01/24/2002 | WO2002006450A1 Pre-adipose cell lines |
| 01/24/2002 | WO2002006448A2 Transformation systems for flavinogenic yeast |
| 01/24/2002 | WO2002006447A2 Salicylic acid biosynthetic genes and uses thereof |
| 01/24/2002 | WO2002006445A2 Transgenic mice containing targeted gene disruptions |
| 01/24/2002 | WO2002006443A2 Lipoxygenase-inducible promoter, expression cassettes comprising same and transformed plants |
| 01/24/2002 | WO2002006440A1 Electrofusion chamber |
| 01/24/2002 | WO2002006345A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 01/24/2002 | WO2002006342A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/24/2002 | WO2002006340A2 Tetraspan protein and uses thereof |
| 01/24/2002 | WO2002006338A1 Vaccine comprising a lung tumour associated antigen |
| 01/24/2002 | WO2002006336A1 A novel polypeptide - human down-regulated in metastasis (drim) protein 13.09 and a polynucleotide encoding the same |
| 01/24/2002 | WO2002006334A1 A novel polypeptide - human large protein 10.01 and a polynucleotide encoding the same |
| 01/24/2002 | WO2002006333A1 A novel polypeptide - pheromone receptor protein vn1-18 and a polynucleotide encoding the same |
| 01/24/2002 | WO2002006332A1 A new polypeptide- human fk506 binding protein 13.42 and the polynucleotide encoding it |
| 01/24/2002 | WO2002006331A2 14087, a serine protease molecule and uses therefor |
| 01/24/2002 | WO2002006330A2 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor |
| 01/24/2002 | WO2002006328A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/24/2002 | WO2002006327A2 A method for prognosing cancer and the proteins involved |
| 01/24/2002 | WO2002006326A2 62088, a human nucleoside phosphatase family member and uses thereof |
| 01/24/2002 | WO2002006325A2 32529, a human guanine nucleotide exchange factor family member and uses thereof |
| 01/24/2002 | WO2002006324A2 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 01/24/2002 | WO2002006323A1 IMMUNOGENIC PROTEINS DERIVED FROM DOMESTIC MITE ALLERGEN, BLOMIA TROPICALIS (Bt5) |
| 01/24/2002 | WO2002006322A2 Polycomb genes mez1 and mez2 from maize |
| 01/24/2002 | WO2002006321A2 Polycomb gene zmfie2 from maize |
| 01/24/2002 | WO2002006320A2 Method for influencing the content of sinapine in transgenic plant cells and plants |
| 01/24/2002 | WO2002006319A2 Nucleic acid molecule which codes for a plant amp deaminase |
| 01/24/2002 | WO2002006318A2 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 01/24/2002 | WO2002006317A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | WO2002006316A2 Alpha-msh related compounds and methods of use |
| 01/24/2002 | WO2002006315A2 Novel nucleic acid and amino acid sequences |
| 01/24/2002 | WO2002006313A2 Regulation of human glutamate receptor delta-1 subunit |
| 01/24/2002 | WO2002006312A2 Disease-associated gene |
| 01/24/2002 | WO2002006311A2 Olfactory g-protein coupled receptor |
| 01/24/2002 | WO2002006306A2 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 01/24/2002 | WO2002006305A1 Method of collecting viral envelope from germinating baculovirus |
| 01/24/2002 | WO2002006303A2 Dna vaccines encoding hiv accessory proteins |
| 01/24/2002 | WO2002006302A2 16816 and 16839, novel human phospholipase c molecules and uses therefor |
| 01/24/2002 | WO2002006297A1 Novel antisense oligonucleotide derivatives against wilms's tumor gene |
| 01/24/2002 | WO2002006282A1 Molecules capable of binding to telomere and the like and method with the use of the same |
| 01/24/2002 | WO2002005930A1 Device and methods for subdividing and filtering gel material and extracting molecules therefrom |
| 01/24/2002 | WO2002005922A1 Method for extracting proteins from plants in pure form |
| 01/24/2002 | WO2002005860A1 Radioligand and binding assay |
| 01/24/2002 | WO2002005857A2 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | WO2002005844A2 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | WO2002005843A2 Human rrp sequences and methods of use |
| 01/24/2002 | WO2002005840A1 Medicinal compositions for promoting fixation of transplanted cells |
| 01/24/2002 | WO2002005749A2 Crf2 ligands in combination therapy |
| 01/24/2002 | WO2002005634A2 Transgenic animal and methods |
| 01/24/2002 | WO2002005633A1 P300 transgenic animal |